Specifically, Mei‐based molecular glues and Mei‐derived PROTACs, such as CRBN‐type and VHL‐type PROTACs, can be designed and synthesized to enhance the degradation of PKMYT1, thereby exhibiting more potent tumor suppressive effects. This evidence concerns the gene PKMYT1 and neoplasm.